Expanding Japanese market entices Indian pharmaceutical firms

03/31/2013 | Business Standard (India)

India-based makers of active pharmaceutical ingredients have made inroads in the Japanese market, with seven APIs approved in Japan for Dishman Pharmaceuticals alone. Indian generic-drug makers also hope to penetrate the market as the Japanese government promotes the use of generic drugs through tax and social security reform.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY